|
Revenue
|
|
$65.2m
|
$275.9m
|
$275.8m
|
$21.7m
|
$30.6m
|
$92.4m
|
|
Gross profit
|
|
$26.3m
|
$106.1m
|
$131.6m
|
$8.8m
|
$15.4m
|
$48.8m
|
|
Administrative and other operating expenses
|
|
($16.6m)
|
($84.0m)
|
($96.1m)
|
($41.4m)
|
($46.7m)
|
($46.4m)
|
|
Other income and other net gains
|
|
($315k)
|
$139k
|
$405k
|
$4.5m
|
$2.7m
|
$614k
|
|
Impairment of goodwill
|
|
—
|
$0
|
$0
|
($3.9m)
|
$0
|
($6.8m)
|
|
Operating loss from continuing operations
|
|
($995k)
|
($10.2m)
|
($23.3m)
|
($51.9m)
|
($48.1m)
|
($44.5m)
|
|
Fair value gain/(loss) on financial assets at fair value through profit or loss
|
|
—
|
—
|
($9.4m)
|
($7.1m)
|
($8.9m)
|
$780k
|
|
Gain on warrant exchange
|
|
—
|
—
|
—
|
$0
|
$0
|
$36.7m
|
|
Fair value (loss)/gain on warrant liabilities
|
|
—
|
$0
|
$3.2m
|
$3.4m
|
$49k
|
($17.9m)
|
|
Unrealized fair value loss on digital assets
|
|
—
|
—
|
—
|
$0
|
$0
|
($9.7m)
|
|
Gain on partial disposal of an equity-accounted investee
|
|
—
|
—
|
$0
|
$0
|
$1.2m
|
$0
|
|
Share of loss of equity-accounted investees, net of tax
|
|
($1.1m)
|
$0
|
$0
|
($859k)
|
($1.8m)
|
($1.3m)
|
|
Loss before taxation
|
|
($3.9m)
|
($170.3m)
|
($183.3m)
|
($56.7m)
|
($57.7m)
|
($36.2m)
|
|
Loss from continuing operations
|
|
—
|
($219.1m)
|
($225.6m)
|
($56.4m)
|
($49.8m)
|
($36.2m)
|
|
Loss from discontinued operations, net of tax
|
|
—
|
$45.1m
|
$35.1m
|
($8.4m)
|
$22k
|
($3.7m)
|
|
Loss for the year
|
|
($2.0m)
|
($174.0m)
|
($190.5m)
|
($64.8m)
|
($49.8m)
|
($40.0m)
|
|
Exchange differences on translation of foreign operations
|
|
$1.6m
|
$260k
|
($4.8m)
|
$1.8m
|
($1.0m)
|
$716k
|
|
Reclassification of cumulative translation reserve upon disposal of foreign operations
|
|
—
|
—
|
—
|
$0
|
$0
|
($74k)
|
|
Equity shareholders of the Company
|
|
($358k)
|
($173.7m)
|
($195.3m)
|
($61.1m)
|
($46.8m)
|
($37.2m)
|
|
Non-controlling interests
|
|
($24k)
|
($8k)
|
($54)
|
($1.9m)
|
($3.7m)
|
($2.2m)
|
|
Basic loss per share (USD per share)
|
|
($0.15)
|
($11.92)
|
($2.50)
|
($5.58)
|
($3.71)
|
($2.68)
|
|
Diluted loss per share (USD per share)
|
|
($0.15)
|
($11.92)
|
($2.50)
|
($5.58)
|
($3.71)
|
($2.68)
|
|
Basic loss per share from continuing operations (USD per share)
|
|
—
|
($225.17)
|
($44.50)
|
($4.83)
|
($3.71)
|
($2.46)
|
|
Diluted loss per share from continuing operations (USD per share)
|
|
—
|
($225.17)
|
($44.50)
|
($4.83)
|
($3.71)
|
($2.46)
|
|
Direct costs
|
|
($38.8m)
|
($169.7m)
|
($144.2m)
|
($12.9m)
|
($15.2m)
|
($43.6m)
|
|
Selling and marketing expenses
|
|
—
|
—
|
—
|
($5.5m)
|
($5.4m)
|
($35.5m)
|
|
Research and development expenses
|
|
($2.8m)
|
($10.6m)
|
($15.5m)
|
($11.7m)
|
($10.9m)
|
($5.1m)
|
|
Other finance costs
|
|
($60k)
|
($5.2m)
|
($4.2m)
|
($120k)
|
($203k)
|
($241k)
|
|
Income tax (expense)/credit
|
|
$1.9m
|
($3.7m)
|
($7.1m)
|
$269k
|
$7.9m
|
($34k)
|
|
Share of other comprehensive (expense)/income of equity-accounted investees
|
|
—
|
—
|
$0
|
$0
|
$303k
|
($26k)
|
|
Other comprehensive income/(expense) for the year
|
|
—
|
—
|
($4.8m)
|
$1.8m
|
($721k)
|
$616k
|
|
Total comprehensive expense for the year
|
|
($383k)
|
($173.8m)
|
($195.3m)
|
($63.0m)
|
($50.5m)
|
($39.4m)
|